CDC advisory panel urges Americans to get Pfizer coronavirus vaccine
Panel rules benefits of inoculation far outweigh risks.
A Centers for Disease Control and Prevention advisory panel voted Saturday to urge Americans to get the nation’s first coronavirus vaccine from Pfizer, concluding its benefits in slowing the pandemic outweigh the risk of side effects.
The CDC panel recommended the vaccine for those 16 years and older, as shipments of vaccine were deployed to hospitals and state health departments for Monday arrival.
Healthcare workers and nursing home patients are expected to be the first recipients of the inoculation
The Pfizer-BioNTech vaccine has been declared to be 95 percent effective after two shots. Its side effects include headaches, fatigue, muscle pain and chills that usually resolve within a few days.
The Food and Drug Administration on late Friday approved the vaccine for emergency use.
News, not Noise
- Gavinomics? California unemployment claims one-third of nation’s total
- Poll: Majority of Americans think COVID-19 threat is getting less serious
- 'Hard to know where pandemic relief money went,' admits federal spending watchdog
- NIH quietly rewrites 'gain-of-function' definition amid greater scrutiny of controversial research
- Souls to Polls: Dem VIPs descend on black churches in Va. to boost turnout for fading McAuliffe